Jim Glasheen, PhD


Jim is a General Partner with Technology Partners and leads the firm’s efforts in Consumer Medicine investing in both medical device and biopharmaceutical companies.

Jim is on the Advisory Council of the Entrepreneurial Center at the University of California, Berkeley and also serves as an advisor to the National Science Foundation’s (NSF) SBIR program in Washington D.C. He is also Co-Chairman of the ConsumerMed Summit.

Prior to joining Technology Partners, Jim was with CIT Venture Capital, where he served as Managing Director, leading the Group’s efforts in Life Science investing. Jim was previously a leader within McKinsey & Company’s Pharmaceutical and Medical Products Practice. Over the course of several years, Jim worked extensively with a broad range of Life Science Companies on M&A, business development and strategic issues.

Jim earned a B.S. from Duke University in Biology / Mechanical Engineering and a M.A. and a Ph.D. from Harvard University in Biology. He also was a Deutsche Akademische Austauschdienst (DAAD) fellow at Universitaet des Saarlandes, Germany and a post-doctoral fellow at University of California, Berkeley. Jim has published several papers and had his research highlighted in several major media outlets, including: Nature, The New York Times, Scientific American, CNN, Die Zeit, and Le Monde.